STAT+: Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
For the third time in less than a year, a group of lawmakers is urging…
Category: Biotech
Opinion: There are 4 gaps in global pandemic responses. The biggest is missing leadership
Three years after news of the first cases of Covid-19 infections and deaths began to…
What’s standing in the way of wastewater data becoming a more mainstream public health tool
When case counts suggest Covid-19 is in check, the truth is in the toilets. The…
Opinion: FTC’s proposed ban on noncompete agreements could be a game changer for some physicians
The last two decades have been a period of declining economic influence for practicing physicians….
Will America’s public health reckoning ever come?
WASHINGTON — After 9/11, Congress created an entirely new government agency to address the threat of…
Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer’s
The air in Mexico City was once so toxic that people watched as dead birds…
STAT+: Insurers hint at suing Biden administration over plans for Medicare Advantage audits
Big health insurers who spoke at the J.P. Morgan Healthcare Conference are gearing up to…
STAT+: Still hoping for looser FDA rules, Regeneron says it will test durable antibody for Covid
SAN FRANCISCO — For months, drugmakers have been pleading with regulators to lower the bar…
STAT+: HHS will decide how to resolve $1 billion in payments for 340B hospitals
WASHINGTON — The Department of Health and Human Services will get to decide how to…
STAT+: FDA scolds Sun Pharmaceutical for serious quality control problems at a key plant in India
Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food…
STAT+: Hospitals say peak labor costs are behind them
SAN FRANCISCO — Rising labor costs has been the main financial concern for hospitals over…
Callers keep flooding 988 mental health, suicide line
HYATTSVILLE, Md. — When Jamieson Brill answers a crisis call from a Spanish speaker on…
STAT+: Illumina, the DNA sequencing giant, gives Wall Street bad news
Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want…
The pandemic showed the power of viral sequencing. Now the U.K. plans to decode other respiratory bugs
Building on the global boom in viral surveillance during the pandemic, U.K. scientists on Tuesday…
An FDA pathway to clear medical devices is putting patients at risk, research suggests
The Food and Drug Administration’s approach to evaluating some new medical devices might actually increase…
STAT+: Pharmalittle: FDA increasingly pauses trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug
Rise and shine, another busy day is on the way. We can tell if only…
.jpg)
Opinion: Is the golden age of biotech stocks over?
Much of the last decade felt like the golden age of biotechnology investing. Money —…
Mistakes happen in research papers. But corrections often don’t
Mistakes happen — in life, in the lab, and, inevitably, in research papers, too. Journals…
With attention to mpox fading, health officials fear infections will go undetected and unreported
In the transmission heyday of the international mpox outbreak early last summer, it appeared that…
STAT+: People hate drug ads on TV. Here’s what they complain about most
In the United States, pharmaceutical advertising seems inescapable. Since the first prescription drug ad ran…
STAT+: FDA’s Califf says congressional report on Aduhelm controversy contained “no surprises”
SAN FRANCISCO – U.S. Food and Drug Administration commissioner Robert Califf doesn’t disagree with the…
Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee
WASHINGTON — The House’s coronavirus committee will continue in a Republican-controlled chamber — but with…
STAT+: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P Morgan
Senior-focused primary care providers Oak Street Health and Agilon Health used their stage time at…
STAT+: New Biogen CEO: New drug launches, more cost cuts, but no ‘radical left turns’ needed
SAN FRANCISCO — In some of his first extended comments since taking over as Biogen’s…
South Dakota plans major ramp up of hepatitis C treatment in prison
WASHINGTON — The head of South Dakota prisons is pledging to dramatically overhaul how the…
STAT+: Rep. Jason Smith and the other Republicans leading health policy in the House
Rep. Jason Smith of Missouri will helm the powerful House Ways & Means Committee this…
STAT+: Moderna plans to follow in Pfizer’s footsteps, charge up to $130 for Covid-19 vaccine in U.S.
Moderna disclosed Monday that it plans to price its Covid-19 vaccine at anywhere from $110…
STAT+: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers
A new study suggests physician practices acquired by private equity rely more heavily on advanced…
STAT+: Novavax replaces CEO, citing need for “fresh perspective”
The vaccine maker Novavax, which has faced several years of dramatic ups and downs around…
STAT+: A flurry of pharma acquisitions kick off JPM week after a slow year for deals
SAN FRANCISCO — Within the first hours of the J.P. Morgan Healthcare Conference, four life…
STAT+: Regeneron’s Eylea sales dip, as competition looms
SAN FRANCISCO — Regeneron said Monday that it collected $1.5 billion in revenues from its…
Telehealth abortion providers eye new options for patients under loosened FDA rules
In the past year, there’s been a significant surge in interest in medication abortion via…
Pediatricians recommend weight-loss drugs and surgery for children with obesity
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications…
STAT+: Pharmalittle: Pediatricians recommend obesity drugs for children; as JPM starts, industry execs have a gloomy financing outlook
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Arrowhead RNA treatment improves liver scarring in patients, but so does a placebo, clouding study results
An experimental RNA treatment reduced liver scarring in half of patients with an inherited disease…
Opinion: Four types of bias in medical AI are running under the FDA’s radar
Although artificial intelligence is entering health care with great promise, clinical AI tools are prone…
STAT+: Mental health data complicate the question of whether telehealth drives up costs
The surge in telehealth during the pandemic promised to shed light on a crucial question:…
India’s lax oversight of pharmaceutical manufacturing imperils health around the world
Cough medicine tainted with ethylene glycol that killed at least 19 children in Uzbekistan in…
‘I want people to see us’: A writer gives voice to long Covid and mothering from bed
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis…
STAT+: BioMarin executives express confidence around hemophilia gene therapy
For years, BioMarin CEO Jean-Jacques “J.J.” Bienaime has been saying that Roctavian — the company’s…
STAT+: Day One says drug shrinks tumors in common pediatric brain cancer, setting up potential approval
Day One Biopharmaceuticals said Sunday that a targeted therapy shrank tumors by at least 50%…
STAT+: The health care providers and insurers we’re watching at JPM23 — and why
Hospitals, health insurers, and other provider-related companies are returning in person to the J.P. Morgan…
STAT+: Money troubles and M&A: What’s on biotech insiders’ minds ahead of a not-so-celebratory JPM week
SAN FRANCISCO — What should be a triumphant return to the global biotech industry’s biggest…
Drugstores make slow headway on staffing problems
Joan Cohrs missed her chance to grab a prescription at her usual drugstore by about…
‘It’s taken longer than I thought’: A former FDA commissioner on the loosened restrictions on abortion pills
When the Food and Drug Administration lifted some — but not all — of its…
STAT+: The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions
Now that the U.S. Food and Drug Administration has granted accelerated approval to the widely…
Officials in Nebraska, South Dakota, Oklahoma begin to probe prisons’ hepatitis C treatment efforts
WASHINGTON — Members of Congress, state legislators, regulators, and legal advocates are calling on prisons…
FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease
The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately…
As respiratory diseases rise, EPA tightens air quality standards
The Environmental Protection Agency announced on Friday more aggressive air quality standards for particulate matter,…
STAT+: Pharmalittle: Pfizer scaling back early-stage research into rare diseases; BioNTech and U.K. partner on cancer trials
And so, another working week will soon draw to a close. Not a moment too…